Comparison of Interferon-Gamma (IFNG) +874 T/A Single Nucleotide Polymorphism in Hepatitis C Virus Infected Patients and Non-Infected Controls in Mashhad, Iran

• Egile Nagusiak: Sina Rostami (Egilea), Alireza Pasdar (Egilea), Sina Gerayli (Egilea), Hamed Hatami (Egilea), Samaneh Sepahi (Egilea), Fatemeh Nategh (Egilea), Mojtaba Meshkat (Egilea), Seyed Mousalreza Hoseini (Egilea), Mitra Ahadi (Egilea), Hamid Reza Sima (Egilea), Hasan Vosughinia (Egilea), Mohammad Reza Sarvghad (Egilea), Abbas Esmaeelzade (Egilea), Hosein Nomani (Egilea), Homan Mosanan Mozafari (Egilea), Fariba Rezai Talab (Egilea), Mohammad Taghi Shakeri (Egilea), Zahra Meshkat (Egilea)
• Formatua: Liburua
• Argitaratua: Iranian Society of Pathology, 2017-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background and Objectives: Interferon-gamma is an important cytokine, which facilitates immunity against intracellular pathogens. Several factors, including genetic variations of cytokine-producing genes have been shown to influence the progression and severity of Hepatitis C virus (HCV) infection....